The observation that the benign nevi carry BRAFV600E mutation suggests that BRAF mutation is not sufficient alone to drive melanoma formation; in line with this observation, most of the mouse studies based on BRAFV600E expression indicate the development of melanocytic nevus-like hyperplasia [192]. This evidence concerns the gene BRAF and melanoma.